Delivering Better at Reuters Pharma USA 2026
Meet with D2 at Reuters Pharma USA
Schedule a 1:1 with our senior strategists to discuss how our track record of 350+ launches and 100+ payer relationships can help you navigate today's complex commercialization and reimbursement landscape. Let’s explore how to eliminate risk from your upcoming milestones and bridge the gap between your therapy and the patients who need it most.
Turn Volatility into Velocity: Build a Go-To-Market Engine That Adapts and Wins
D2 Solutions is the proud to sponsor and participate in this year’s panel discussion: "Turn Volatility into Velocity: Build a Go-To-Market Engine That Adapts and Wins” at Reuters Pharma USA 2026.
In an increasingly unpredictable market, the difference between growing and beinig left behind lies in the agility of your commercial strategy. This session brings together industry leaders, including our CEO, Dean Erhardt, to discuss how manufacturers can accelerate decisions, drive script growth, and expand market penetration.
Patients are becoming the CEOs of their healthcare journey.
"Imagine a healthcare process where patients are engaged and equipped with the information they need to make decisions in a logical, manageable way. This transformation is about more than just simplifying a complex system—it’s about enabling patients to access treatments and therapies that are personalized to their unique health needs." Read More
